Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.5 (EPT/RI) - Inspired Plc
-
Form 8.5 (EPT/RI) - H&T Group Plc
-
Result of the auction of treasury bills on 11 June 2025
-
Form 8.5 (EPT/RI) - Greencore Group Plc
-
Form 8.5 (EPT/RI) - Anexo Group Plc
-
Form 8.5 (EPT/RI)-Craneware plc
-
Form 8.5 (EPT/RI)-Thruvision Group plc
-
Form 8.5 (EPT/RI)-Dowlais Group plc
-
Correction: Offentliggørelse af prospekter, Investeringsforeningen Maj Invest
-
Form 8.5 (EPT/RI)- De La Rue plc
-
Form 8.5 (EPT/RI)-Anexo Group plc
-
CHESS Health Solutions' Pharmacist-Supported Hypertension Model Delivers 9:1 ROI, Improves Patient Outcomes
-
Mattermost Names James Mullins as Vice President of Sales for EMEA and APAC
-
Colliers publishes 2024 Global Sustainability Report
-
CHESS Health Solutions' Pharmacist-Supported Hypertension Model Delivers 9:1 ROI, Improves Patient Outcomes
-
Replacement in bonds for new lending - Nykredit Realkredit A/S
-
Form 8.3 - Spectris plc
-
TRESU Investment Holding A/S – Management changes
-
Treatment.com AI Announces New Medical Education Suite to Enhance Clinical Skills Training Through AI-Simulated Patients
-
Offentliggørelse af prospekter, Investeringsforeningen Maj Invest
-
Offentliggørelse af prospekt for Investeringsforeningen Nordea Invest
-
CREDIT AGRICOLE FINANCEMENT DE L'HABITAT SFH : EARLY REPURCHASE OF ISIN FR001400JLZ4
-
Angelini Ventures Invests into €11.25 Million Seed Round for Elkedonia to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders
-
Elkedonia closes EUR 11 million seed round to advance neuroplastogens as novel therapeutics for depression and neuropsychiatric disorders
-
Angelini Ventures Invests into €11.25 Million Seed Round for Elkedonia to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders
-
LEADING EDGE MATERIALS ANNOUNCES UP TO $4,000,000 NON-BROKERED PRIVATE PLACEMENT
-
Elkedonia closes EUR 11 million seed round to advance neuroplastogens as novel therapeutics for depression and neuropsychiatric disorders
-
IREN prices upsized $500 million convertible notes offering
-
AB Artea bankas own shares acquisition programme completed
-
TCM Group A/S: Major shareholder announcement
-
Bitget CEO Gracy Chen Featured in Coindesk's Top 50 Women in Web3 and AI
-
Bitget CEO Gracy Chen Featured in Coindesk's Top 50 Women in Web3 and AI
-
Crusoe Announces Strategic European Expansion with First Data Center in Norway, Partnering with Polar
-
WSP to acquire Ricardo, a global strategic and engineering consultancy firm
-
MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies
-
Turntide Unveils Expanded Range of Gen 6 Inverters and New Turntide Turnkey Solutions Partner at iVT Expo 2025
-
Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 6)
-
Notification of Share Transaction
-
NBPE - Transaction in Own Shares
-
Persica strengthens global IP portfolio with EU patent granted for PP353
-
AGM Statement
-
tpay Releases White Paper on the Transformative Power of Open Banking Across the Middle East
-
UREVO Announces Skiing Champion Brothers as Brand Ambassadors
-
NKT A/S concludes share buyback programme
-
Transaction in Own Shares
-
CROSSJECT advances on the development of ZEPIZURE® Junior, its solution for epilepsy crises in children
-
ONWARD Medical Schedules Webcast to Provide Q1 2025 Business Update and Year-To-Date Highlights
-
Fnac Darty implements a share buyback program
-
Net Asset Value of EfTEN Real Estate Fund AS as of 31 May 2025
-
Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU
